Jones Hill Capital LP — 13F Holdings & Portfolio
CIK 2102314 · latest 13F-HR filed 2026-05-14
Jones Hill Capital LP manages $466.5M in 13F-reported U.S. long-equity assets across 26 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are BMRN (15.36%), VRTX (10.40%), PCVX (8.03%).
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$466.5M
Long-equity book
26
Distinct positions
2026-03-31
Filed 2026-05-14
—
no prior filing cached
| Name | Title / Status | Ownership | Type |
|---|
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | BIOMARIN PHARMACEUTICAL INC | BMRN | 09061G101 | $71.7M | 15.36% | 1,268,390 | SH |
| 2 | VERTEX PHARMACEUTICALS INC | VRTX | 92532F100 | $48.5M | 10.40% | 108,603 | SH |
| 3 | VAXCYTE INC | PCVX | 92243G108 | $37.5M | 8.03% | 644,831 | SH |
| 4 | NUVALENT INC | NUVL | 670703107 | $30.8M | 6.61% | 300,830 | SH |
| 5 | CAPRICOR THERAPEUTICS INC | CAPR | 14070B309 | $27.6M | 5.93% | 909,207 | SH |
| 6 | TERNS PHARMACEUTICALS INC | TERN | 880881107 | $27.5M | 5.89% | 521,237 | SH |
| 7 | BICARA THERAPEUTICS INC | BCAX | 055477103 | $25.1M | 5.37% | 1,260,136 | SH |
| 8 | ANI PHARMACEUTICALS INC | ANIP | 00182C103 | $24.5M | 5.25% | 318,591 | SH |
| 9 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 90400D108 | $24.4M | 5.23% | 1,165,557 | SH |
| 10 | ENLIVEN THERAPEUTICS INC | ELVN | 29337E102 | $23.2M | 4.98% | 593,040 | SH |
| 11 | AMYLYX PHARMACEUTICALS INC | AMLX | 03237H101 | $22.2M | 4.76% | 1,598,794 | SH |
| 12 | ARGENX SE | ARGX | 04016X101 | $19.0M | 4.07% | 25,995 | SH |
| 13 | FULCRUM THERAPEUTICS INC | FULC | 359616109 | $13.6M | 2.91% | 1,771,926 | SH |
| 14 | VIR BIOTECHNOLOGY INC | VIR | 92764N102 | $10.7M | 2.30% | 1,198,213 | SH |
| 15 | NUVATION BIO INC | NUVB | 67080N101 | $10.2M | 2.19% | 2,383,031 | SH |
| 16 | ORUKA THERAPEUTICS INC | ORKA | 687604108 | $6.9M | 1.48% | 140,843 | SH |
| 17 | CONTINEUM THERAPEUTICS INC | CTNM | 21217B100 | $6.7M | 1.44% | 513,053 | SH |
| 18 | VERADERMICS INC | MANE | 922967104 | $6.4M | 1.37% | 100,843 | SH |
| 19 | TONIX PHARMACEUTICALS HLDG C | TNXP | 890260839 | $6.2M | 1.33% | 452,116 | SH |
| 20 | STRUCTURE THERAPEUTICS INC | GPCR | 86366E106 | $4.8M | 1.04% | 100,593 | SH |
| 21 | ENTRADA THERAPEUTICS INC | TRDA | 29384C108 | $4.7M | 1.01% | 374,010 | SH |
| 22 | PHARVARIS N V | PHVS | N69605108 | $4.7M | 1.01% | 167,014 | SH |
| 23 | TREVI THERAPEUTICS INC | TRVI | 89532M101 | $4.4M | 0.95% | 370,175 | SH |
| 24 | RELMADA THERAPEUTICS INC | RLMD | 75955J402 | $2.4M | 0.51% | 342,752 | SH |
| 25 | SILENCE THERAPEUTICS PLC | SLN | 82686Q101 | $1.6M | 0.34% | 301,604 | SH |
| 26 | ARRIVENT BIOPHARMA INC | AVBP | 04272N102 | $1.1M | 0.23% | 45,809 | SH |